Dysfunctional activity of classical DNA end-joining renders acquired resistance to carboplatin in human ovarian cancer cells
出版年份 2021 全文链接
标题
Dysfunctional activity of classical DNA end-joining renders acquired resistance to carboplatin in human ovarian cancer cells
作者
关键词
Ovarian cancer, Chemoresistance, DNA damage Response, DNA repair, Non-homologous end joining
出版物
CANCER LETTERS
Volume 520, Issue -, Pages 267-280
出版商
Elsevier BV
发表日期
2021-08-08
DOI
10.1016/j.canlet.2021.08.003
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Mechanisms of Multidrug Resistance in Cancer Chemotherapy
- (2020) Karol Bukowski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mitochondria participate in chemoresistance to cisplatin in human ovarian cancer cells
- (2020) Luca X Zampieri et al. MOLECULAR CANCER RESEARCH
- Visualizing and interpreting cancer genomics data via the Xena platform
- (2020) Mary J. Goldman et al. NATURE BIOTECHNOLOGY
- Deficiency in classical nonhomologous end-joining–mediated repair of transcribed genes is linked to SCA3 pathogenesis
- (2020) Anirban Chakraborty et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer
- (2020) Sanghoon Lee et al. Cell Reports
- Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression
- (2019) Junli Deng et al. BMC CANCER
- Prosthesis design influences segmental contribution to total cervical motion after cervical disc arthroplasty
- (2019) Avinash G. Patwardhan et al. EUROPEAN SPINE JOURNAL
- Ovarian Cancer Immunotherapy: Turning up the Heat
- (2019) Eleonora Ghisoni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Modulation of the Apoptosis Gene Bcl-x Function Through Alternative Splicing
- (2019) Megan Stevens et al. Frontiers in Genetics
- Regulation of DNA repair in the absence of classical non-homologous end joining
- (2018) Youn-Jung Kang et al. DNA REPAIR
- Homologous recombination and the repair of DNA double-strand breaks
- (2018) William Douglass Wright et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chemoresistance and the Self-Maintaining Tumor Microenvironment
- (2018) Gulcen Yeldag et al. Cancers
- Nonhomologous DNA end-joining for repair of DNA double-strand breaks
- (2017) Nicholas R. Pannunzio et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BCL-XL overexpression promotes tumor progression-associated properties
- (2017) Daniela Trisciuoglio et al. Cell Death & Disease
- Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma
- (2017) Jennifer Ducie et al. Nature Communications
- Contribution of classical end-joining to PTEN inactivation in p53-mediated glioblastoma formation and drug-resistant survival
- (2017) Youn-Jung Kang et al. Nature Communications
- The molecular mechanisms of chemoresistance in cancers
- (2017) Hua-Chuan Zheng Oncotarget
- PARP inhibitors in ovarian cancer: evidence, experience and clinical potential
- (2017) Tarra Evans et al. Therapeutic Advances in Medical Oncology
- Radiation Treatment in Women with Ovarian Cancer: Past, Present, and Future
- (2017) Emma C. Fields et al. Frontiers in Oncology
- Adipocyte microenvironment promotes Bclxl expression and confers chemoresistance in ovarian cancer cells
- (2016) Carlos Cardenas et al. APOPTOSIS
- Ovarian Cancers Harbor Defects in Nonhomologous End Joining Resulting in Resistance to Rucaparib
- (2016) Aiste McCormick et al. CLINICAL CANCER RESEARCH
- Immune checkpoint inhibition in ovarian cancer
- (2016) Junzo Hamanishi et al. INTERNATIONAL IMMUNOLOGY
- DNA Double-Strand Break Repair Inhibitors as Cancer Therapeutics
- (2015) Mrinal Srivastava et al. CHEMISTRY & BIOLOGY
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA Damage Response Factors from Diverse Pathways, Including DNA Crosslink Repair, Mediate Alternative End Joining
- (2015) Sean M. Howard et al. PLoS Genetics
- DNA repair mechanisms in cancer development and therapy
- (2015) Alessandro Torgovnick et al. Frontiers in Genetics
- MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer
- (2014) Zsófia Pénzváltó et al. BMC CANCER
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Novel role for non-homologous end joining in the formation of double minutes in methotrexate-resistant colon cancer cells
- (2014) Xiangning Meng et al. JOURNAL OF MEDICAL GENETICS
- Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches
- (2014) Felix Dietlein et al. TRENDS IN GENETICS
- COSMIC (Cohort Studies of Memory in an International Consortium): An international consortium to identify risk and protective factors and biomarkers of cognitive ageing and dementia in diverse ethnic and sociocultural groups
- (2013) Perminder S Sachdev et al. BMC Neurology
- Analysis on Outcome of 3537 Patients with Coronary Artery Disease: Integrative Medicine for Cardiovascular Events
- (2013) Zhu-ye Gao et al. Evidence-based Complementary and Alternative Medicine
- Loss of DOK2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis
- (2013) Elena Lum et al. GYNECOLOGIC ONCOLOGY
- Signal Transduction Pathways and Transcriptional Mechanisms of ABCB1/Pgp-mediated Multiple Drug Resistance in Human Cancer Cells
- (2013) H Sui et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Optimal first-line treatment in ovarian cancer
- (2012) F. A. Raja et al. ANNALS OF ONCOLOGY
- New Insight into P-Glycoprotein as a Drug Target
- (2012) Albert Breier et al. Anti-Cancer Agents in Medicinal Chemistry
- Fast gapped-read alignment with Bowtie 2
- (2012) Ben Langmead et al. NATURE METHODS
- Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications
- (2011) S. E. Polo et al. GENES & DEVELOPMENT
- Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells
- (2011) A. G. Patel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Poly(ADP-Ribose) Polymerase Is Hyperactivated in Homologous Recombination-Defective Cells
- (2010) P. Gottipati et al. CANCER RESEARCH
- Development of a Functional Assay for Homologous Recombination Status in Primary Cultures of Epithelial Ovarian Tumor and Correlation with Sensitivity to Poly(ADP-Ribose) Polymerase Inhibitors
- (2010) A. Mukhopadhyay et al. CLINICAL CANCER RESEARCH
- γH2AX: a sensitive molecular marker of DNA damage and repair
- (2010) L-J Mah et al. LEUKEMIA
- ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
- (2009) Gabriela Bindea et al. BIOINFORMATICS
- DNA damage induced by cis- and carboplatin as indicator for in vitro sensitivity of ovarian carcinoma cells
- (2009) Florian T Unger et al. BMC CANCER
- MicroRNAs in ovarian carcinomas
- (2009) Neetu Dahiya et al. ENDOCRINE-RELATED CANCER
- Impaired DNA damage response — An Achilles' heel sensitizing cancer to chemotherapy and radiotherapy
- (2009) Zbigniew Darzynkiewicz et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- First-line treatment of advanced ovarian cancer: current research and perspectives
- (2009) Claudia Marchetti et al. Expert Review of Anticancer Therapy
- FAUregulates carboplatin resistance in ovarian cancer
- (2009) Esther L. Moss et al. GENES CHROMOSOMES & CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search